PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
Related Experiment Video
Updated: Oct 20, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Tian Xia1, Ming Liu2, Quan Zhao2
1Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, People's Republic of China.
Abstract:
Protein arginine methyltransferase 5 (PRMT5), a histone methyltransferase responsible for the symmetric dimethylation of histone H4 on Arg 3 (H4R3me2s), is an enzyme that participates in tumor cell progression in a variety of hematological malignancies. However, the biological functions of PRMT5 in multiple myeloma (MM) and the underlying molecular mechanisms remain unclear. In this study, we conducted a bioinformatics analysis and found that PRMT5 expression was significantly upregulated in MM. In vitro and in vivo phenotypic experiments revealed that knockdown of PRMT5 expression enhanced cell pyroptosis in MM. Moreover, we found that CASP1 expression was negatively correlated with PRMT5 expression, and repressing PRMT5 expression rescued both the phenotype and expression markers (N-GSDMD, IL-1b, and IL-18). Inhibition of PRMT5 activity increased CASP1 expression and promoted MM cell pyroptosis. Finally, high expression of PRMT5 or low expression of CASP1 was correlated with poor overall survival in MM. Collectively, our results provide a mechanism by which PRMT5 regulates cell pyroptosis by silencing CASP1 in MM.
Insights
Protein arginine methyltransferase 5 (PRMT5) is upregulated in multiple myeloma (MM) and suppresses cell death. Inhibiting PRMT5 promotes pyroptosis by increasing CASP1, improving survival in MM patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Protein arginine methyltransferase 5 (PRMT5) is implicated in hematological malignancies.
- The role and mechanisms of PRMT5 in multiple myeloma (MM) are not fully understood.
Purpose of the Study:
- To investigate the function of PRMT5 in MM.
- To elucidate the molecular mechanisms by which PRMT5 influences MM progression and cell death.
Main Methods:
- Bioinformatic analysis of PRMT5 expression in MM.
- In vitro and in vivo knockdown experiments of PRMT5.
- Assays to assess cell pyroptosis and expression of key markers (CASP1, N-GSDMD, IL-1β, IL-18).
Main Results:
- PRMT5 expression is significantly upregulated in MM.
- PRMT5 knockdown enhances MM cell pyroptosis.
- PRMT5 negatively regulates CASP1 expression, and its inhibition restores pyroptosis.
- High PRMT5 or low CASP1 expression correlates with poor survival in MM.
Conclusions:
- PRMT5 promotes MM progression by suppressing CASP1-mediated pyroptosis.
- Targeting PRMT5 may represent a therapeutic strategy for MM by reactivating cell death pathways.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Caspases
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Extrinsic Apoptotic Pathway

